The global market for Organ and Tissue Transplantation is projected to reach 177 Thousand Procedures by 2024, driven by increasing cases of organ failure, growing infectious and other chronic diseases, and stepped-up efforts from various agencies to increase awareness.
Organ transplantation refers to a procedure where an organ or tissue is removed from a body and replaced with another corresponding organ or tissue from another body is referred to as transplantation. The term covers a wide range of tissues including whole organs or a section of the organ. Transplantation of organs is a life-saving process often opted as last resort to save or prolong life of a patient with diseased organ or failed tissues. Aging population, increasing life expectancy and growing incidence of chronic diseases are the major factors driving demand for organ replacements. However, market growth is directly dependent on organs available for transplant with organ donation being the limiting factor. Growth in the market is currently driven by increasing supply driven by growing awareness. Enhanced knowledge of organ transplantation along with concurrent advancements in immunosuppression agents, organ preservation solutions and anti-infective drugs has improved success rates or transplant procedures and patient survival post transplantation, which is further contributing to demand growth.
Deceased organs remain the major source of organs for transplantation, as use of living sources is largely confined to kidneys. Kidney transplantation continues to be the most common transplant procedure globally, followed by liver and heart transplants. On the other hand, cornea and musculoskeletal graft transplantations are the widely conducted tissue transplant procedures. A major hurdle to growth in the market is the long and growing waiting list for organ transplantation, which results in considerable number of deaths each year. Black market organ sourcing and medical tourism are a result of this huge supply-demand gap. However, stringent regulations to prevent black marketing have been espoused in recent years with a focus on patient safety and emphasis on developing the legal side of the market. In addition, increasing investments on R&D are anticipated to offer new solutions and help the market to grow further in the coming years.
Europe represents the largest market worldwide. The organ and tissue transplantation market globally is characterized by elements of both an evolving and mature markets. With a higher number of procedures each year, developed markets in Europe and the US lead global organ transplantation volumes. However, these markets are relatively mature with limited potential for growth in organ donations, while emerging markets in Asia-Pacific and Latin America bode significant prospects ahead. Asia-Pacific represents the fastest growing market worldwide, with a CAGR of 6.6% through the analysis period. Growing awareness, lower procedural costs and increasing donors are driving medical tourism in some countries such as China and India, driving overall markets growth.
Major players in the market include Acelity L.P. Inc., CryoLife, Inc., Exactech, Inc., Dr. Franz Kohler Chemie GmbH, Organogenesis, Inc., Organ Recovery Systems, Organ Transport Systems and XVIVO Perfusion AB among others.